Postdoctoral researcher

University of Chicago

Dr. Caner Saygin`s lab at the Univ of Chicago is seeking motivated postdoc researchers to study leukemia biology and new experimental therapeutics.

See the full job description on jobRxiv: https://jobrxiv.org/job/university-of-chicago-27778-postdoctoral-researcher-2/?feed_id=49041

#ScienceJobs #hiring #research #leusm
Chicago #UnitedStatesUS #Postdoc...
https://jobrxiv.org/job/university-of-chicago-27778-postdoctoral-researcher-2/?feed_id=49041

Postdoctoral researcher

University of Chicago

Dr. Caner Saygin`s lab at the Univ of Chicago is seeking motivated postdoc researchers to study leukemia biology and new experimental therapeutics.

See the full job description on jobRxiv: https://jobrxiv.org/job/university-of-chicago-27778-postdoctoral-researcher-2/?feed_id=48432

#ScienceJobs #hiring #research #leusm
Chicago #UnitedStatesUS #Postdoc...
https://jobrxiv.org/job/university-of-chicago-27778-postdoctoral-researcher-2/?feed_id=48432

Senior Research Technologist @CanerSaygin

The Senior Research Technologist will work on research projects involving both in vitro and in vivo investigations in leukemia.

https://jobrxiv.org/job/university-of-chicago-27778-senior-research-technologist/?feed_id=43506

#ScienceJobs #job #leukemia #leusm #genomics #transg...
https://jobrxiv.org/job/university-of-chicago-27778-senior-research-technologist/?feed_id=43506

The March #StemCellEvidence Alert is out! If you don't receive it free in your inbox, sign up and see this month's top ten references here: http://www.stemcellevidence.com/alerts
#BMT #leusm #mmsm #lymsm

T-replete #cord transplants give superior outcomes in high risk and relapsed/refractory paediatric myeloid malignancy Our top article this month in the #StemCellEvidence Alert by Claire Horgan et al in @BloodAdvances
stemcellevidence.com/article/366495…
#leusm #BMT

Why not in Japan? @PMDA_JPN
---
RT @AML_Hub
🚨 NEWS 🚨
Oral ivosidenib, an IDH1 inhibitor, receives a positive opinion from the CHMP of the EMA for the treatment of patients with IDH1-mutated AML. This opinion is based on data from the AGILE trial.
https://loom.ly/7yv6z94
#leusm #mednews
https://twitter.com/AML_Hub/status/1630569392202194944

RT @Anand_88_Patel@twitter.com

Reminder about our January 31st @HemeReports@twitter.com AML Twitter Spaces event with @Daver_Leukemia@twitter.com @AkEisfeld@twitter.com @CLachowiez@twitter.com @jaltmanmd@twitter.com #leusm

@sanamloghavi@twitter.com @KMirza@twitter.com @NitinJainMD@twitter.com @doctorpemm@twitter.com

https://twitter.com/i/spaces/1lDxLnNyBnwGm

🐦🔗: https://twitter.com/Anand_88_Patel/status/1620084382039166977

RT @Anand_88_Patel@twitter.com

Very excited to announce the next @HemeReports@twitter.com Twitter Spaces event! We will be covering AML #ASH22 abstracts with @Daver_Leukemia@twitter.com @AkEisfeld@twitter.com @CLachowiez@twitter.com @jaltmanmd@twitter.com #leusm

@sanamloghavi@twitter.com @KMirza@twitter.com @NitinJainMD@twitter.com @doctorpemm@twitter.com

Set a reminder here: https://twitter.com/i/spaces/1lDxLnNyBnwGm

🐦🔗: https://twitter.com/Anand_88_Patel/status/1618260166977413121

RT @KMirza@twitter.com

Stain quality is crucial #hemepath #pathology #leusm
click here to learn more: https://kikoxp.com/posts/16027/public

🐦🔗: https://twitter.com/KMirza/status/1615732850770288641

RT @KMirza@twitter.com

Stain quality is crucial #hemepath #pathology #leusm
click here to learn more: https://kikoxp.com/posts/16027/public

🐦🔗: https://twitter.com/KMirza/status/1615732850770288641

RT @KMirza@twitter.com

Stain quality is crucial #hemepath #pathology #leusm
click here to learn more: https://kikoxp.com/posts/16027/public

🐦🔗: https://twitter.com/KMirza/status/1615732850770288641

Stain quality is crucial #hemepath #pathology #leusm
click here to learn more: https://kikoxp.com/posts/16027/public

RT @sanamloghavi@twitter.com

Looking forward to reading this in detail.Big #hemepath #leusm and #MRD implications Congrats to the authors. Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia ⁦⁦@BloodAdvances@twitter.com⁩ https://ashpublications.org/bloodadvances/article/7/1/167/486809/Integrated-flow-cytometry-and-sequencing-to

🐦🔗: https://twitter.com/sanamloghavi/status/1612937159874420736

One of our top ten picks in the #StemCellEvidence Alert this month: Boyiadzis et al in Leukemia journal on Impact of pre-transplant induction and consolidation cycles on #AML allogeneic transplant outcomes: a CIBMTR analysis
http://www.stemcellevidence.com/article/36310182
#BMT #leusm

Incredible to see continuously trending #ASH22 and related hashtags across chats/conferences/diseases/other categories! Stoked to see #lymsm #mmsm #leusm #cardiacpath #path2path #meded #lymphoma in the mix too!

RT @sanamloghavi@twitter.com

Ending #ASH22 on a high note with great friends & colleagues and amazing #IsraeliFood Thank you to all of our expert colleagues who have contributed to @HemeReports@twitter.com so far! Looking forward to more great episodes next year. #hemepath #leusm #mmsm https://www.hemereports.com

🐦🔗: https://twitter.com/sanamloghavi/status/1602521881176948738

RT @majorajay@twitter.com

1/3 of pts with MDS reported financial toxicity, and 10% of pts skipped medications or changed dosing because they could not afford their medications. 12% borrowed money or went into debt to pay. We must be screening for FT! #leusm #ASH22 cc @UDurani@twitter.com @FayUCCancerCr@twitter.com

Next bolus of @ASH_hematology@twitter.com #ASH22 patient-reported outcomes abstracts in this thread! #MajorPROs #MajorPROsASH

Distress on NCCN Distress Thermometer = inferior overall survival in AML. What drives this and amenable to intervention? #leusm

RT @CyclingDoctor@twitter.com

Today @ 3:30
Tracking the Evolution of Therapy-Related Myeloid Neoplasms Using Chemotherapy Signatures

#ASH22 #mmsm #leusm #mdssm
@KellyLBolton@twitter.com

https://ash.confex.com/ash/2022/webprogram/Paper158992.html

🐦🔗: https://twitter.com/CyclingDoctor/status/1602308037552885761

RT @doctorpemm@twitter.com

#ASH22 | ➡️ A Truly epic ASH Presidents Reception #NOLA #Superdome | 🙌quality time w/friends ⁦@doctorpemm@twitter.com⁩ ⁦⁦.⁦@AaronGerds@twitter.com⁩ .⁦@jaltmanmd@twitter.com⁩ .@mpdrc@twitter.com⁩ #MPNSM #leusm ⁦@ASH_hematology@twitter.com⁩ 🙏🏾👏🏽❤️🔥🙌 ⁦@ASHClinicalNews@twitter.com⁩ #ASHKudos #ASHTogether

🐦🔗: https://twitter.com/doctorpemm/status/1602163444903546880